Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share (BJDX)

14 filings reported holding BJDX - Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Bluejay Diagnostics, Inc. - Common Stock, par value $0.0001 per share (BJDX) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.02M shares of 27M outstanding shares and own 3.77% of the company stock.
Largest 10 shareholders include Anson Funds Management LP (319K shares), SABBY MANAGEMENT, LLC (305K shares), RENAISSANCE TECHNOLOGIES LLC (137K shares), UBS Group AG (61.4K shares), TWO SIGMA SECURITIES, LLC (52.6K shares), CITADEL ADVISORS LLC (52.2K shares), HRT FINANCIAL LP (39.6K shares), GEODE CAPITAL MANAGEMENT, LLC (20.2K shares), TWO SIGMA INVESTMENTS, LP (11K shares), and Jump Financial, LLC (10.4K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.